The evidence for a key metabolic role of CD36 in TAM-mediated metastasis is strong, therefore targeting the related metabolites and FAs involved in the metabolism may provide an emerging approach for cancer treatment and manipulation of TAMs. This evidence concerns the gene CD36 and cancer.